Company Filing History:
Years Active: 2010
Title: **Fred Immermann: Innovator in Drug Activity Monitoring**
Introduction
Fred Immermann is a notable inventor based in Suffern, NY, recognized for his contributions to pharmacology and drug monitoring technology. With a focus on innovative methods to enhance drug activity monitoring, his work plays a significant role in advancing medical research.
Latest Patents
Fred Immermann holds a patent for "Methods for monitoring drug activities in vivo." This patent details methods, systems, and equipment effective for monitoring the in vivo activities of CCI-779 and other drugs. The invention identifies numerous drug activity genes that can be evaluated, as their expression profiles in peripheral blood mononuclear cells are modulated by CCI-779 or similar drugs. Consequently, these genes serve as surrogate markers for detecting or monitoring drug activities in vivo, thus providing critical insights into drug efficacy.
Career Highlights
Immermann is associated with Wyeth, a prominent pharmaceutical company known for its research and development in various therapeutic areas. His contributions within this organization have been instrumental in pioneering innovative solutions that enhance drug monitoring and patient care.
Collaborations
Throughout his career, Fred has collaborated with respected colleagues such as Michael E. Burczynski and Joseph Boni. These partnerships have fostered a productive environment for innovation and research, enabling significant advancements in the understanding of drug activities.
Conclusion
Fred Immermann's dedication to the field of drug monitoring and his innovative insights into pharmacogenomics establish him as a key figure in medical research. His patent serves as a valuable tool for scientists and healthcare professionals, contributing to better patient outcomes and the advancement of pharmacological science.